<?xml version="1.0" encoding="UTF-8"?>
<paload id="" version="">
	<toplevel>
		<routedMedId>165500</routedMedId>
		<routedMedName>Sovaldi oral</routedMedName>
		<routedGenericName>sofosbuvir oral</routedGenericName>
		<etcIds>
			<etc_id>6434</etc_id>
		</etcIds>
		<medIds>
			<medId>580421</medId>
		</medIds>
	</toplevel>
	<diagnoses>
		<diagnosis>
			<fqn>Chronic Hepatitis C - Genotype 1</fqn>
			<age>
				<ageRangeType>ge</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>nocode</gender>
			<icd9>22.14194</icd9>
			<symbolic>ChronVirHepCGen1</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype_name>
				<name/>
			</subtype_name>
			<severity>
				<name/>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name>Gastroenterology</name>
					<code>207RG0100X</code>
				</prescriber>
				<prescriber>
					<name>Hepatology</name>
					<code>207RI0008X</code>
				</prescriber>
				<prescriber>
					<name>Infectious Disease</name>
					<code>207RI0200X</code>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name/>
					<code/>
					<severity_name/>
					<severity_code/>
					<subtype_name/>
					<inclusion_exclusion>inclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>all</typeName>
						<treatment>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.57024</codeValues>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.57024</codeValues>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Olysio </name>
								<codeValues>1.243545 </codeValues>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>sofosbuvir </name>
								<codeValues>1.243945 </codeValues>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<treatment>
							<dosing/>
							<rating>ratherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.57024</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12-24</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12-24</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<dosing/>
							<rating>rtherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<treatmentLine>
									<option>WITH</option>
									<interventionType>drug</interventionType>
									<name>Sovaldi  </name>
									<codeValues>1.243965</codeValues>
									<durModifier>nocode</durModifier>
									<dur>12</dur>
									<durUnit>w</durUnit>
									<timeFrame>nocode</timeFrame>
								</treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Olysio </name>
								<codeValues>1.243545 </codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<treatmentLine>
									<option>WITH</option>
									<interventionType>drug</interventionType>
									<name>Sovaldi  </name>
									<codeValues>1.243965</codeValues>
									<durModifier>nocode</durModifier>
									<dur>12</dur>
									<durUnit>w</durUnit>
									<timeFrame>nocode</timeFrame>
								</treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<dosing/>
							<rating>rtherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>						
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Olysio </name>
								<codeValues>1.243545 </codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<dosing/>
							<rating>ratherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<durModifier>nocode</durModifier>
								<dur>24</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</concurrenttherapy>
			<triedtherapy/>
			<triedTherapyExclusion/>
			<concurrentTherapyExclusion/>
			<dosing>
				<text>400 mg orally every day</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>580421</medId>
					<initPerDayDesc>1 tablet</initPerDayDesc>
					<initPerIntervalDesc>168 tablets per 24 weeks</initPerIntervalDesc>
					<renewPerDayDesc>not applicable</renewPerDayDesc>
					<renewPerIntervalDesc>not applicable</renewPerIntervalDesc>
				</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</initialDur>
				<renewalDur>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</renewalDur>
				<overallMax>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>AASLD/IDSA/IASâ€“USA. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. Accessed February 12, 2014.</reference>
				<reference>Sovaldi [package insert]. Foster City Oaks, CA: Gilead ISciences, Inc; 2014</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
			<alternatives>
			</alternatives>
		</diagnosis>
		<diagnosis>
			<fqn>Chronic Hepatitis C - Genotype 2</fqn>
			<age>
				<ageRangeType>ge</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>nocode</gender>
			<icd9>22.14330</icd9>
			<symbolic>ChronVirHepCGen2</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype_name>
				<name/>
			</subtype_name>
			<severity>
				<name/>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name>Gastroenterology</name>
					<code>207RG0100X</code>
				</prescriber>
				<prescriber>
					<name>Hepatology</name>
					<code>207RI0008X</code>
				</prescriber>
				<prescriber>
					<name>Infectious Disease</name>
					<code>207RI0200X</code>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name/>
					<code/>
					<severity_name/>
					<severity_code/>
					<subtype_name/>
					<inclusion_exclusion>inclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>all</typeName>
						<treatment>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.1.57024</codeValues>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<treatment>
							<dosing/>
							<rating>rtherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<dosing/>
							<rating>atherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.1.57024</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</concurrenttherapy>
			<triedtherapy/>
			<triedTherapyExclusion/>
			<concurrentTherapyExclusion/>
			<dosing>
				<text>400 mg orally every day</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>580421</medId>
					<initPerDayDesc>1 tablet</initPerDayDesc>
					<initPerIntervalDesc>84 tablets per 12 weeks</initPerIntervalDesc>
					<renewPerDayDesc>not applicable</renewPerDayDesc>
					<renewPerIntervalDesc>not applicable</renewPerIntervalDesc>
					</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>12</dur>
					<durUnit>w</durUnit>
				</initialDur>
				<renewalDur>
					<dur>12</dur>
					<durUnit>w</durUnit>
				</renewalDur>
				<overallMax>
					<dur>12</dur>
					<durUnit>w</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>AASLD/IDSA/IASâ€“USA. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. Accessed February 12, 2014.</reference>
				<reference>Sovaldi [package insert]. Foster City Oaks, CA: Gilead ISciences, Inc; 2014</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
			<alternatives>
			</alternatives>
		</diagnosis>
		<diagnosis>
			<fqn>Chronic Hepatitis C - Genotype 3</fqn>
			<age>
				<ageRangeType>ge</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>nocode</gender>
			<icd9>22.14331</icd9>
			<symbolic>ChronVirHepCGen3</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype_name>
				<name/>
			</subtype_name>
			<severity>
				<name/>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name>Gastroenterology</name>
					<code>207RG0100X</code>
				</prescriber>
				<prescriber>
					<name>Hepatology</name>
					<code>207RI0008X</code>
				</prescriber>
				<prescriber>
					<name>Infectious Disease</name>
					<code>207RI0200X</code>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name/>
					<code/>
					<severity_name/>
					<severity_code/>
					<subtype_name/>
					<inclusion_exclusion>inclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>nocode</typeName>
						<treatment>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.57024</codeValues>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<treatment>
							<dosing/>
							<rating>rtherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>24</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>nocode</durModifier>
								<dur>24</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<dosing/>
							<rating>atherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.57024</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</concurrenttherapy>
			<triedtherapy/>
			<triedTherapyExclusion/>
			<concurrentTherapyExclusion/>
			<dosing>
				<text>400 mg orally once a day</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>580421</medId>
					<initPerDayDesc>1 tablet</initPerDayDesc>
					<initPerIntervalDesc>168 tablets per 24 weeks</initPerIntervalDesc>
					<renewPerDayDesc>not applicable</renewPerDayDesc>
					<renewPerIntervalDesc>not applicable</renewPerIntervalDesc>
					</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</initialDur>
				<renewalDur>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</renewalDur>
				<overallMax>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>AASLD/IDSA/IASâ€“USA. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. Accessed February 12, 2014.</reference>
				<reference>Sovaldi [package insert]. Foster City Oaks, CA: Gilead ISciences, Inc; 2014</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
			<alternatives>
			</alternatives>
		</diagnosis>
		<diagnosis>
			<fqn>Chronic Hepatitis C - Genotype 4</fqn>
			<age>
				<ageRangeType>ge</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>nocode</gender>
			<icd9>22.14332</icd9>
			<symbolic>ChronVirHepCGen4</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype_name>
				<name/>
			</subtype_name>
			<severity>
				<name/>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name>Gastroenterology</name>
					<code>207RG0100X</code>
				</prescriber>
				<prescriber>
					<name>Hepatology</name>
					<code>207RI0008X</code>
				</prescriber>
				<prescriber>
					<name>Infectious Disease</name>
					<code>207RI0200X</code>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name/>
					<code/>
					<severity_name/>
					<severity_code/>
					<subtype_name/>
					<inclusion_exclusion>inclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>nocode</typeName>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.57024</codeValues>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<treatment>
							<dosing/>
							<rating>rtherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.57024</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							
						</treatment>
						<treatment>
							<dosing/>
							<rating>rtherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>24</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
								<durModifier>nocode</durModifier>
								<dur>24</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</concurrenttherapy>
			<triedtherapy/>
			<triedTherapyExclusion/>
			<concurrentTherapyExclusion/>
			<dosing>
				<text>400 mg orally every day</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>580421</medId>
					<initPerDayDesc>1 tablet</initPerDayDesc>
					<initPerIntervalDesc>168 tablets per 24 weeks</initPerIntervalDesc>
					<renewPerDayDesc>not applicable</renewPerDayDesc>
					<renewPerIntervalDesc>not applicable</renewPerIntervalDesc>
				</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</initialDur>
				<renewalDur>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</renewalDur>
				<overallMax>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>AASLD/IDSA/IASâ€“USA. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. Accessed February 12, 2014.</reference>
				<reference>Sovaldi [package insert]. Foster City Oaks, CA: Gilead ISciences, Inc; 2014</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
			<alternatives>
			</alternatives>
		</diagnosis>
		<diagnosis>
			<fqn>Chronic Hepatitis C - Genotype 5 or 6</fqn>
			<age>
				<ageRangeType>ge</ageRangeType>
				<ageRangeMin>18</ageRangeMin>
				<ageRangeMax/>
				<ageRangeUnit>y</ageRangeUnit>
				<ageDesc/>
			</age>
			<gender>nocode</gender>
			<icd9>23.14333</icd9>
			<symbolic>ChronVirHepCGen5or6</symbolic>
			<rating>labeledDx</rating>
			<genotype>
				<name/>
			</genotype>
			<polymorphism>
				<name/>
			</polymorphism>
			<subtype_name>
				<name/>
			</subtype_name>
			<severity>
				<name/>
				<code/>
				<dur/>
				<durUnit>nocode</durUnit>
			</severity>
			<prescribers>
				<prescriber>
					<name>Gastroenterology</name>
					<code>207RG0100X</code>
				</prescriber>
				<prescriber>
					<name>Hepatology</name>
					<code>207RI0008X</code>
				</prescriber>
				<prescriber>
					<name>Infectious Disease</name>
					<code>207RI0200X</code>
				</prescriber>
			</prescribers>
			<comorbidities>
				<comorbidity>
					<name/>
					<code/>
					<severity_name/>
					<severity_code/>
					<subtype_name/>
					<inclusion_exclusion>inclusion</inclusion_exclusion>
					<dur/>
					<durUnit>nocode</durUnit>
				</comorbidity>
			</comorbidities>
			<concurrenttherapy>
				<criteriaSet>
					<patientHxType>
						<typeName>all</typeName>
						<treatment>
							<treatmentLine>
								<option>OR</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.57024</codeValues>
								<selectedListName/>
								<selectedListClassCode/>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
							</treatmentLine>
						</treatment>
					</patientHxType>
					<preferredTherapy>
						<treatment>
							<dosing/>
							<rating>rtherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>peginterferon alfa-2a</name>
								<codeValues>1.57024</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<durModifier>nocode</durModifier>
								<dur>12</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
						<treatment>
							<dosing/>
							<rating>atherapy</rating>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>Sovaldi  </name>
								<codeValues>1.243965</codeValues>
								<durModifier>nocode</durModifier>
								<dur>24</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
							<treatmentLine>
								<option>WITH</option>
								<interventionType>drug</interventionType>
								<name>ribavirin</name>
								<codeValues>1.12883</codeValues>
								<durModifier>nocode</durModifier>
								<dur>24</dur>
								<durUnit>w</durUnit>
								<timeFrame>nocode</timeFrame>
							</treatmentLine>
						</treatment>
					</preferredTherapy>
				</criteriaSet>
			</concurrenttherapy>
			<triedtherapy/>
			<triedTherapyExclusion/>
			<concurrentTherapyExclusion/>
			<dosing>
				<text>400 mg orally every day</text>
			</dosing>
			<instructions>
				<instruction/>
			</instructions>
			<qlimits>
				<qlimit>
					<medId>580421</medId>
					<initPerDayDesc>1 tablet</initPerDayDesc>
					<initPerIntervalDesc>168 tablets per 24 weeks</initPerIntervalDesc>
					<renewPerDayDesc>not applicable</renewPerDayDesc>
					<renewPerIntervalDesc>not applicable</renewPerIntervalDesc>
				</qlimit>
			</qlimits>
			<durations>
				<initialDur>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</initialDur>
				<renewalDur>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</renewalDur>
				<overallMax>
					<dur>12-24</dur>
					<durUnit>w</durUnit>
				</overallMax>
			</durations>
			<references>
				<reference>AASLD/IDSA/IASâ€“USA. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. Accessed February 12, 2014.</reference>
				<reference>Sovaldi [package insert]. Foster City Oaks, CA: Gilead ISciences, Inc; 2014</reference>
			</references>
			<precautions>
				<precaution>
					<text/>
					<severity/>
				</precaution>
			</precautions>
			<alternatives>
			</alternatives>
		</diagnosis>
	</diagnoses>
	<precautions>
		<geriatric>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</geriatric>
		<pregnancy>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</pregnancy>
		<pediatric>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</pediatric>
		<lactation>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</lactation>
		<allergy>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</allergy>
		<sideEffect>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</sideEffect>
		<drugDisease>
			<caution>
				<drug/>
				<severity/>
				<text/>
			</caution>
		</drugDisease>
	</precautions>
	<lists/>
</paload>
